Evidence map›Paper›PMID 41581665›Full record

ArticleMolecular & cellular proteomics : MCP2026

Deciphering Stiffness-Driven Changes in Colorectal Cancer by Proteomics.

Charlotte Cresens, Ana Montero-Calle, Guillermo Solís-Fernández, Behrad Shaghaghi, Lotte Gerrits, Samet Aytekin, Paul H J Kouwer, Rodrigo Barderas, Susana Rocha

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Charlotte CresensMolecular Imaging and Photonics Division, Chemistry Department, Faculty of Sciences, KU Leuven, Heverlee, Belgium.
Ana Montero-CalleChronic Disease Programme, UFIEC, Instituto de Salud Carlos III, Madrid, Spain.
Guillermo Solís-FernándezMolecular Imaging and Photonics Division, Chemistry Department, Faculty of Sciences, KU Leuven, Heverlee, Belgium; Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, Madrid, Spain.
Behrad ShaghaghiMolecular Materials Group, Institute for Molecules and Materials, Faculty of Science, Radboud University, AJ Nijmegen, The Netherlands.
Lotte GerritsMolecular Materials Group, Institute for Molecules and Materials, Faculty of Science, Radboud University, AJ Nijmegen, The Netherlands; Institute for Chemical Immunology, AJ Nijmegen, The Netherlands.
Samet AytekinMolecular Imaging and Photonics Division, Chemistry Department, Faculty of Sciences, KU Leuven, Heverlee, Belgium.
Paul H J KouwerMolecular Materials Group, Institute for Molecules and Materials, Faculty of Science, Radboud University, AJ Nijmegen, The Netherlands.
Rodrigo BarderasChronic Disease Programme, UFIEC, Instituto de Salud Carlos III, Madrid, Spain; CIBER Frailty and Healthy Aging (CIBERFES), Madrid, Spain. Electronic address: r.barderasm@isciii.es.
Susana RochaMolecular Imaging and Photonics Division, Chemistry Department, Faculty of Sciences, KU Leuven, Heverlee, Belgium. Electronic address: susana.rocha@kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor stiffening plays a pivotal role in cancer progression. Increased tumor stiffness, resulting from interactions between cancer cells and their surrounding microenvironment, alters the tumor's mechanical properties and significantly impacts cancer growth and metastasis, the primary cause of cancer-related death. Despite the importance of tumor stiffness, systematic studies exploring its effect on protein dysregulation are limited. In this study, focused on colorectal cancer, we show by in-depth proteomics that matrix stiffness significantly alters the expression of secreted proteins, while intracellular protein levels remain largely unaffected. Functional assays reveal that the changes observed by proteomics in the secretome, driven by matrix stiffness, enhance cell migration, angiogenesis, and matrix remodeling, which collectively would contribute to a more aggressive cancer phenotype in a real scenario. Our findings emphasize the critical role of matrix stiffness in driving colorectal cancer progression through changes in the secretome, offering valuable insights for the development of biomechanical cancer therapies.

Indexed as

Colorectal NeoplasmsProteomicsCell Line, TumorCell MovementExtracellular MatrixHumansNeovascularization, PathologicProteomeSecretomeTumor MicroenvironmentProteomecolorectal cancerfunctional assaysintracellular and secreted proteomeproteomicssecretometumor stiffness

Identifiers

PMID41581665
PMCPMC12964026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.